Takeda to Acquire Envoy

Takeda America Holdings is to acquire Envoy. Takeda America Holdings will acquire 100 percent of the equity in Envoy for total consideration of up to $140 million, which includes an up-front payment and progress-dependent, preclinical milestone payments. Envoy is a privately-held drug discovery company focused on finding new drugs with superior efficacy and fewer side effects than existing treatments. Takeda’s corporate venture arm, Takeda Ventures, participated in Envoy’s series A financing in October 2009.

DealsNorth AmericaUSBriefs